This inventor holds 3 USPTO granted patents. Top assignees: Transgene S.a., Smithkline Beecham Biologicals S.a., The United States of America as Represented by the Department of Health. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Heverlee-Egenhoven, BE (2000)
- Hoegaarden, BE (2000 - 2002)
Company Filing History:
2 out of 159 
1 out of 75 
1 out of 1,217 
Years Active: 2000-2002
Title: Wilfried Dalemans: Innovator in Nucleic Acid Vaccination
Introduction
Wilfried Dalemans is a notable inventor based in Hoegaarden, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid vaccination. With a total of 3 patents to his name, Dalemans has focused on enhancing immune responses and developing innovative vectors for gene therapy.
Latest Patents
Dalemans' latest patents include a method to enhance an immune response of nucleic acid vaccination. This invention provides a method to enhance an immune response by the simultaneous administration of a polynucleotide and a polypeptide of interest. Another significant patent is related to a replication deficient recombinant adenovirus vector. This invention involves a vector in which an expression cassette comprising the DNA fragment coding for the human CFTR protein is inserted, with the gene being under the control of the endogenous human CFTR promoter.
Career Highlights
Throughout his career, Wilfried Dalemans has worked with prominent companies in the biotechnology sector. He has been associated with Transgene S.A. and SmithKline Beecham Biologicals S.A., where he contributed to various innovative projects. His work has had a lasting impact on the development of therapeutic solutions in the field of immunology.
Collaborations
Dalemans has collaborated with notable professionals in his field, including Michel Perricaudet and Leslie Stratford-Perricaudet. These collaborations have further enriched his research and development efforts, leading to advancements in biotechnology.
Conclusion
Wilfried Dalemans stands out as an influential inventor in the realm of biotechnology, particularly in nucleic acid vaccination. His innovative patents and collaborations have significantly contributed to advancements in the field, showcasing his dedication to improving health outcomes through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile